Delong Liu Selected Research

Doxorubicin (Adriamycin)

1/2014	CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function.
10/2012	Novel CD20 monoclonal antibodies for lymphoma therapy.
8/2012	Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Delong Liu Research Topics

Disease

47	Neoplasms (Cancer) 02/2023 - 08/2004
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 08/2002
10	Lymphoma (Lymphomas) 01/2023 - 05/2005
9	Leukemia 11/2019 - 08/2002
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 08/2002
7	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 08/2002
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 08/2002
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018 - 01/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 01/2016
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 08/2011
5	Multiple Myeloma 01/2020 - 10/2019
5	Lymphoid Leukemia 01/2019 - 11/2015
5	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 01/2004
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 06/2004
4	Carcinogenesis 10/2014 - 01/2004
3	Hemorrhage 11/2023 - 06/2009
3	Infections 11/2023 - 10/2010
3	Breast Neoplasms (Breast Cancer) 01/2023 - 02/2014
3	Neutropenia 10/2021 - 11/2010
3	Bites and Stings (Sting) 01/2020 - 11/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 10/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 08/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 11/2010
3	Melanoma (Melanoma, Malignant) 04/2013 - 02/2012
2	Scoliosis 10/2022 - 08/2020
2	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 01/2020 - 01/2018
2	Lung Neoplasms (Lung Cancer) 11/2019 - 04/2013
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2014
2	Cytokine Release Syndrome 01/2018 - 01/2014
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2017 - 03/2016
2	Babesiosis (Piroplasmosis) 01/2017 - 01/2017
2	Heart Diseases (Heart Disease) 01/2016 - 04/2012
2	Edema (Dropsy) 11/2010 - 05/2008
2	Exanthema (Rash) 11/2010 - 02/2009
2	Hepatocellular Carcinoma (Hepatoma) 11/2010 - 02/2007
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2010 - 06/2009
1	Cysts 11/2023

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2012
10	Chimeric Antigen ReceptorsIBA 07/2021 - 01/2014
8	ibrutinibIBA 12/2017 - 08/2013
7	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 08/2013
7	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 11/2012
6	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2009
6	isothiocyanic acidIBA 11/2010 - 01/2004
5	AntibodiesIBA 01/2021 - 11/2012
5	EnzymesIBA 01/2021 - 12/2006
5	Monoclonal AntibodiesIBA 11/2019 - 10/2012
5	blinatumomabIBA 01/2019 - 11/2012
5	Imatinib Mesylate (Gleevec)FDA Link 11/2010 - 05/2004
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2013
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 05/2006
4	Messenger RNA (mRNA)IBA 10/2011 - 08/2006
3	B-Cell Maturation AntigenIBA 01/2020 - 01/2019
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018 - 11/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2016
3	phenethyl isothiocyanate (PEITC)IBA 05/2016 - 08/2004
3	Histones (Histone)IBA 01/2016 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2016 - 08/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 08/2012
3	Prednisone (Sone)FDA LinkGeneric 01/2014 - 08/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 08/2012
3	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 01/2004
2	Therapeutic UsesIBA 02/2023 - 06/2009
2	SodiumIBA 01/2023 - 01/2022
2	Tumor Biomarkers (Tumor Markers)IBA 05/2022 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 11/2011
2	AntigensIBA 07/2021 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2019
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020 - 11/2019
2	ElastinIBA 01/2020 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 01/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2013
2	Inotuzumab OzogamicinIBA 01/2019 - 01/2019
2	Gemtuzumab (Mylotarg)FDA Link 01/2019 - 01/2019
2	gilteritinibIBA 01/2019 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 10/2018 - 11/2012
2	CaspasesIBA 12/2017 - 01/2004
2	osimertinibIBA 01/2017 - 01/2016
2	AndrogensIBA 05/2016 - 01/2004
2	selinexorIBA 01/2015 - 10/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2015 - 03/2006
2	Vincristine (Oncovin)FDA LinkGeneric 10/2012 - 08/2012
2	Rituximab (Mabthera)FDA Link 10/2012 - 08/2012
2	IpilimumabIBA 03/2012 - 02/2012
2	Vorinostat FDA Link 02/2010 - 06/2009
2	ChromatinIBA 02/2010 - 05/2006
2	Histone Deacetylase InhibitorsIBA 02/2010 - 06/2009
2	CarcinogensIBA 12/2006 - 05/2006
2	IsothiocyanatesIBA 12/2006 - 05/2006
2	Temozolomide (Temodar)FDA LinkGeneric 06/2004 - 08/2002

Therapy/Procedure

40	Therapeutics 01/2023 - 03/2006
18	Immunotherapy 07/2021 - 09/2015
10	Drug Therapy (Chemotherapy) 01/2021 - 05/2005
3	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2021 - 12/2018
2	Chemoradiotherapy 02/2023 - 01/2016
2	Induction Chemotherapy 10/2021 - 07/2005
2	Endoscopes 02/2014 - 06/2009
1	Transcranial Direct Current Stimulation 11/2023
1	Lymph Node Excision (Lymph Node Dissection) 02/2023